Verhagen PC - Search Results

1

Verhagen PC, Nikkels PG, de Jong TP. Verhagen PC, et al. Arch Dis Child. 2001 Apr;84(4):344-6. doi: 10.1136/adc.84.4.344. Arch Dis Child. 2001. PMID: 11259238 Free PMC article. Review.

2

Prognostic factors in localised prostate cancer with emphasis on the application of molecular techniques.

Verhagen PC, Tilanus MG, de Weger RA, van Moorselaar RJ, van den Tweel JG, Boon TA. Verhagen PC, et al. Eur Urol. 2002 Apr;41(4):363-71. doi: 10.1016/s0302-2838(02)00048-9. Eur Urol. 2002. PMID: 12074805 Review.

3

Percutaneous nephrolithotomy for treating renal calculi in children.

Boormans JL, Scheepe JR, Verkoelen CF, Verhagen PC. Boormans JL, et al. Among authors: verhagen pc. BJU Int. 2005 Mar;95(4):631-4. doi: 10.1111/j.1464-410X.2005.05351.x. BJU Int. 2005. PMID: 15705093

4

Reduction of serum prostate-specific antigen levels following varicella-zoster infection and valaciclovir treatment in prostate cancer.

Jurhill RR, van der Veen H, van Leenders GJ, Verhagen PC. Jurhill RR, et al. Among authors: verhagen pc. Eur Urol. 2009 Aug;56(2):392-4. doi: 10.1016/j.eururo.2009.02.025. Epub 2009 Feb 28. Eur Urol. 2009. PMID: 19278776

5

Diagnostic value of urinary dysmorphic erythrocytes in clinical practice.

Crop MJ, de Rijke YB, Verhagen PC, Cransberg K, Zietse R. Crop MJ, et al. Among authors: verhagen pc. Nephron Clin Pract. 2010;115(3):c203-12. doi: 10.1159/000313037. Epub 2010 Apr 23. Nephron Clin Pract. 2010. PMID: 20413998

6

Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers.

Verhagen PC, Zhu XL, Rohr LR, Cannon-Albright LA, Tavtigian SV, Skolnick MH, Brothman AR. Verhagen PC, et al. Cancer Genet Cytogenet. 2000 Oct 1;122(1):43-8. doi: 10.1016/s0165-4608(00)00276-4. Cancer Genet Cytogenet. 2000. PMID: 11104032

7

Deletion of chromosomal region 6q14-16 in prostate cancer.

Verhagen PC, Hermans KG, Brok MO, van Weerden WM, Tilanus MG, de Weger RA, Boon TA, Trapman J. Verhagen PC, et al. Int J Cancer. 2002 Nov 10;102(2):142-7. doi: 10.1002/ijc.10677. Int J Cancer. 2002. PMID: 12385009 Free article.

8

Current vaccination strategies for prostate cancer.

Joniau S, Abrahamsson PA, Bellmunt J, Figdor C, Hamdy F, Verhagen P, Vogelzang NJ, Wirth M, Van Poppel H, Osanto S. Joniau S, et al. Eur Urol. 2012 Feb;61(2):290-306. doi: 10.1016/j.eururo.2011.09.020. Epub 2011 Oct 3. Eur Urol. 2012. PMID: 22001436 Review.

9

Expression of the androgen-regulated fusion gene TMPRSS2-ERG does not predict response to endocrine treatment in hormone-naïve, node-positive prostate cancer.

Boormans JL, Hermans KG, Made AC, van Leenders GJ, Wildhagen MF, Collette L, Schröder FH, Trapman J, Verhagen PC. Boormans JL, et al. Among authors: verhagen pc. Eur Urol. 2010 May;57(5):830-5. doi: 10.1016/j.eururo.2009.08.013. Epub 2009 Aug 22. Eur Urol. 2010. PMID: 19716227

10

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.

Boevé LMS, Hulshof MCCM, Vis AN, Zwinderman AH, Twisk JWR, Witjes WPJ, Delaere KPJ, Moorselaar RJAV, Verhagen PCMS, van Andel G. Boevé LMS, et al. Eur Urol. 2019 Mar;75(3):410-418. doi: 10.1016/j.eururo.2018.09.008. Epub 2018 Sep 25. Eur Urol. 2019. PMID: 30266309 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page